CN Stock MarketDetailed Quotes

Ginwa Enterprise(Group) Inc. (600080)

Watchlist
  • 8.80
  • +0.18+2.09%
Not Open Apr 8 15:00 CST
3.28BMarket Cap41.90P/E (TTM)

Ginwa Enterprise(Group) Inc. (600080) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drug sales240.59M99.71%
Other701.82K0.29%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical industry241.08M99.91%
Pharmaceutical commerce214.71K0.09%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
North China region156.49M26.73%
East China region123.49M21.09%
Northwest region85.54M14.61%
Southwest region59.67M10.19%
Northeast region52.72M9.01%
Central China region43.91M7.50%
South China region43.4M7.41%
South Central region19.58M3.34%
Total special adjustments651.4K0.11%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More